New Vision Helps Sysmex America Expand the Use of ThingWorx Platform to Transform the Patient Experi
Recently, New Vision teamed up with Sysmex to help them revolutionize the XW-100 – The first automated hematology analyzer developed for CLIA-waived use.
Instead of sending blood samples to outside laboratories and awaiting the results, the XW-100 makes it possible for one of the most frequently requested blood tests, the CBC, to be performed in medical offices where patients are first treated. On-site blood test results are available to patients in as few as three minutes.
That’s a staggering 480 times faster than before!
So, how did we do it?
ThingWorx and the Internet of Things (IoT).
The Industrial Innovation Platform enabled Sysmex and New Vision to greatly expand the availability of product data and implement transformative connected solutions that were previously beyond reach. Prior to the XW-100, virtually all hematology analyzers required skilled clinical personnel to perform blood sample analysis and validate results. This ground-breaking innovation enables blood tests to be safely performed by a broader range of practitioners, improving access to and speed of care.
ThingWorx is leading the way to new horizons – don’t miss it!
For more information, check out the New Vision services page.